Confocal Microscopy for Coating Characterization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The challenge lies in controlling and monitoring the uniformity of drug coatings on implantable medical devices, such as stents, to ensure accurate drug delivery, particularly in aqueous biological environments where water-insoluble drugs may fail to release effectively, and in managing polymorphic forms of drugs like paclitaxel that complicate dosage and coverage.
Innovation Solution
A method utilizing confocal microscopy to determine the three-dimensional distribution of polarization active compounds in coatings, allowing for precise measurement of drug distribution and thickness, using polarized optical microscopy and specific wavelengths like 786 nm, 380 nm, or 229 nm to characterize the amount and distribution of compounds like crystalline paclitaxel polymorphs, even in the presence of carrier materials.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If conventional optical microscopy is used to monitor coating uniformity, then the measurement process is simple, but the measurement precision and three-dimensional distribution characterization are insufficient
Solution Approach 1:
The patent segments the optical measurement process into multiple focal planes at different depths within the coating. By capturing images at multiple planes and processing them separately, the system achieves three-dimensional characterization of drug distribution while maintaining manageable complexity through systematic data organization and processing
Solution Approach 2:
The patent transitions from two-dimensional surface imaging to three-dimensional volumetric measurement by introducing the depth dimension through multiple focal planes. This dimensional expansion enables precise characterization of drug distribution throughout the coating thickness, not just at the surface
2Manufacturing precision
If confocal microscopy with multiple focal planes is used, then three-dimensional drug distribution can be characterized, but the device complexity and measurement time increase
Solution Approach 1:
The patent performs preliminary actions by capturing all necessary images at multiple focal planes before any processing occurs. The complete three-dimensional dataset is acquired in advance, allowing for efficient offline processing and analysis without requiring iterative measurements or adjustments during the analysis phase
Solution Approach 2:
The patent creates optical copies of the coating at different focal planes through confocal microscopy. Each plane provides a two-dimensional cross-section of the three-dimensional structure, and these optical copies are processed independently and then integrated to reconstruct the complete drug distribution profile
3Ease of manufacture
If drug coating is applied directly onto stent surface, then the coating process is simple, but the drug distribution uniformity and coverage control are difficult
Solution Approach 1:
The patent implements feedback by using optical measurement to characterize the actual drug distribution after coating application. This measurement data provides feedback on coating uniformity and coverage, enabling process optimization and quality control to achieve more consistent drug dosing in subsequent manufacturing runs
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables precise characterization and uniform distribution of therapeutic agents on implantable devices, ensuring effective drug delivery and overcoming issues related to polymorphic forms and aqueous environments, thereby enhancing the efficacy of local treatment in medical procedures.
Implementation Method 1
utilizing optical microscopy, such as confocal microscopy, to obtain images at a number of planes at differing axial positions
Data Source
AI summary
The present invention generally relates to methods for determining the presence and distribution of a polarization active material present in a coating. In one embodiment, the coating is present on an implantable device, for example an implantable stent.